Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TUNN, E. J.
Right arrow Articles by BACON, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TUNN, E. J.
Right arrow Articles by BACON, P. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology


other

DIFFERENTIATING PERSISTENT FROM SELF-LIMITING SYMMETRICAL SYNOVITIS IN AN EARLY ARTHRITIS CLINIC

E. J. TUNN and P. A. BACON

Department of Rheumatology, University of Birmingham Birmingham B15 2TJ

Correspondence to: Correspondence to Dr E. Tunn, Rheumatic Diseases Unit, Royal Liverpool University Hospital, Liverpool L7 8XP

Early rheumatoid arthritis (RA) must be differentiated from benign self-limiting polyarthritis because of the risks associated with treatment of RA. Conventional, widely available clinical and laboratory variables, measured at first clinic visit, were studied for their ability to predict persistance in 112 patients with up to 6 months ofjoint symptoms. Those 65 patients with symmetrical peripheral polyarthritis were followed for 1 year: 36 who underwent spontaneous remission were classified self-limiting synovitis (SLS); the remaining 29 were termed persistent synovitis (PS). Univariate analysis suggested more severe disease in PS at presentation but showing considerable overlap with SLS, making clinical discrimination difficult. Multivariate analysis confirmed this overlap but identified a subset of most helpful variables. The RA latex was the most powerful variable, yet accounted for only 45% of the variability in outcome. Combining a positive RA latex with an ESR>30 mm/h carried a relative risk for PS of 4.33, with specificity 94% but sensitivity only 69%. Self-limiting synovitis initially could not be distinguished from early RA: hence RA may exist in two forms, the traditional persistent form and a less well recognized abortive form.

KEY WORDS: Early rheumatoid arthritis, Acute polyarthritis, Persistent synovitis, Multivariate analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
D. P. M. Symmons
Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
Rheumatology, May 1, 2007; 46(5): 725 - 726.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. P. Machold, T. A. Stamm, V. P. K. Nell, S. Pflugbeil, D. Aletaha, G. Steiner, M. Uffmann, and J. S. Smolen
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease
Rheumatology, February 1, 2007; 46(2): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E Suresh and C M Lambert
Combination treatment strategies in early rheumatoid arthritis
Ann Rheum Dis, September 1, 2005; 64(9): 1252 - 1256.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
E Suresh
Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know
J R Soc Med, September 1, 2004; 97(9): 421 - 424.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
J S Smolen and D Aletaha
Patients with rheumatoid arthritis in clinical care
Ann Rheum Dis, March 1, 2004; 63(3): 221 - 225.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
L M A Jansen, D van Schaardenburg, I E van der Horst-Bruinsma, and B A C Dijkmans
One year outcome of undifferentiated polyarthritis
Ann Rheum Dis, August 1, 2002; 61(8): 700 - 703.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Emery, F C Breedveld, M Dougados, J R Kalden, M H Schiff, and J S Smolen
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
Ann Rheum Dis, April 1, 2002; 61(4): 290 - 297.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. A. Quinn, P. G. Conaghan, and P. Emery
The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?
Rheumatology, November 1, 2001; 40(11): 1211 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F M McQueen, N Benton, J Crabbe, E Robinson, S Yeoman, L McLean, and N Stewart
What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease
Ann Rheum Dis, September 1, 2001; 60(9): 859 - 868.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
B. Harrison and D. Symmons
Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years
Rheumatology, September 1, 2000; 39(9): 939 - 949.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
B. J. Harrison, A. J. Silman, D. P. M. Symmons, C. T. Pease, B. Bhakta, J. Devlin, and P. Emery
Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors
Rheumatology, January 1, 2000; 39(1): 112 - 113.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
J L Hülsemann and H Zeidler
Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic
Ann Rheum Dis, May 1, 1999; 58(5): 278 - 280.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
R. Munro, R. Hampson, A. McEntegart, E A. Thomson, R. Madhok, and H. Capell
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study
Ann Rheum Dis, February 1, 1998; 57(2): 88 - 93.
[Abstract] [Full Text]


Home page
NEJMHome page
J. M. Cash and J. H. Klippel
Second-Line Drug Therapy for Rheumatoid Arthritis
N. Engl. J. Med., May 12, 1994; 330(19): 1368 - 1375.
[Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.